Erasca, Inc. (ERAS)
3.725
+0.18
(+5.23%)
USD |
NASDAQ |
Dec 31, 16:00
3.725
0.00 (0.00%)
After-Hours: 20:00
Erasca Market Cap: 1.057B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GT Biopharma, Inc. | 8.429M |
| ALX Oncology Holdings, Inc. | 61.54M |
| Prelude Therapeutics, Inc. | 181.37M |
| Foghorn Therapeutics, Inc. | 303.11M |
| Atea Pharmaceuticals, Inc. | 279.69M |
Market Cap Related Metrics
| Price to Book Value | 3.038 |
| Price | 3.725 |
| Earnings Yield | -12.10% |